Condition
PDA
Total Trials
5
Recruiting
0
Active
0
Completed
4
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
20%
1 trials in Phase 3/4
Results Transparency
0%
0 of 4 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
2Total
P 1 (1)
P 3 (1)
Trial Status
Completed4
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT05321849Completed
Echocardiography-guided Percutaneous Patent Ductus Arteriosus Closure
NCT04379843CompletedPrimary
The Efficacy of Implementing a Treatment Algorithm in Managing Patent Ductus Arteriosus (PDA) in the Extremely Low Birth Weight Neonatal Population.
NCT01755728Phase 3CompletedPrimary
Paracetamol (Acetaminophen) for Closure of PDA in Preterm Infants
NCT02396004CompletedPrimary
NIRS in PDA VLBW Infants
NCT01149564Phase 1Unknown
Comparison of Oral and Intravenous Ibuprofen for PDA Treatment in Premature Infants
Showing all 5 trials